Olix reached a $3.3 billion valuation, making founder James Dacombe Europe’s youngest self-made billionaire amid the AI inference boom.

British founder James Dacombe began programming at age 13 and launched his first technology company at 17. A recent $312 million funding round for AI chip startup Olix has elevated the company’s valuation to $3.3 billion, placing Dacombe among a select group of young, self-made billionaires.

Dacombe’s ascent into billionaire status traces back to a decision made long before artificial intelligence emerged as a dominant force in global technology investment. After starting to code at 13, he quickly found conventional education losing its appeal. Dacombe left sixth-form college in Harrogate after just two days and, at 17, pivoted entirely to entrepreneurship. Eight years on, the 25-year-old British entrepreneur has founded two technology companies and, according to Forbes estimates, stands as Europe’s youngest self-made billionaire.

The catalyst for this milestone is Olix. The London-based AI chip startup closed a $312 million funding round in early August, pushing its valuation to $3.3 billion. Just six months prior, Olix was valued at slightly over $1 billion following a $220 million financing round in February. This rapid appreciation in private-market valuation fundamentally altered the calculus of Dacombe’s personal wealth. Forbes estimates Dacombe holds approximately 30% of Olix. At the current valuation, that stake is worth nearly $1 billion on paper. His additional equity in brain-technology firm CoMind further compounds his net worth. This represents an extraordinary trajectory for a founder who only established the precursor to Olix in 2024.

Before turning to AI infrastructure, Dacombe focused on brain technology. While Olix drove his most recent wealth surge, it was not Dacombe’s first venture into complex technology development. At 17, he founded CoMind, a medical technology firm developing non-invasive systems for brain monitoring. The company is engineering tools that provide clinicians with real-time data on cerebral blood flow and other neurological metrics without requiring invasive procedures. Dacombe continues to serve as CoMind’s founder and chief executive. In 2025, CoMind secured $102.5 million to fund clinical trials, navigate regulatory pathways, and prepare for manufacturing its inaugural product. The company has not publicly disclosed its valuation. Forbes estimates Dacombe retains a 12% ownership stake in CoMind. His early entrepreneurial efforts also earned him a spot in the Thiel Fellowship, a program founded by technology investor Peter Thiel to support young founders bypassing traditional university paths. Dacombe has previously framed youth as a strategic advantage in entrepreneurship. He argues that a relative absence of entrenched caution allows younger founders to pursue unconventional approaches that seasoned professionals might prematurely dismiss. That mindset ultimately carried him across two distinct technical domains: neurotechnology and artificial intelligence infrastructure.

Olix is betting on post-training AI compute. The billionaire designation captures only one dimension of Olix’s trajectory. The company is developing specialized processors tailored for AI inference—the phase where a trained model processes new inputs to generate outputs or responses. Olix is also integrating photonic interconnects, leveraging light-based data transmission to boost performance and energy efficiency while reducing the operational costs of large-scale AI models. The company is entering a market dominated by Nvidia, but Olix bets that the next evolution of AI compute will demand workload-specific processors rather than reliance on a single general-purpose architecture. This strategy remains a technological wager rather than a proven commercial reality. Olix anticipates finalizing its chip design by late 2026, with commercial product deliveries slated for 2027. Despite the timeline, investors have already assigned a multibillion-dollar valuation to this ambition. The latest funding round was led by New York-based investment firm Fundomo. Participating investors include British semiconductor designer Arm, quantitative trading firm Hudson River Trading, Netflix co-founder Reed Hastings, and the UK government-backed Sovereign AI Fund. Olix now employs over 140 staff across offices in London, Bristol, Toronto, and the United States. For a venture founded in 2024, this expansion rate is notably rapid.

How a six-month valuation surge reshaped Dacombe’s wealth. These figures clarify why Dacombe’s profile has recently transcended the tech sector. Following a $220 million raise in February, Olix was valued at just over $1 billion. By early August, a subsequent $312 million injection pushed the valuation to $3.3 billion. For an individual holding roughly 30% of the company, this repricing carries profound financial implications. It remains critical to distinguish private-equity wealth from liquid capital. Both Olix and CoMind remain privately held. Their valuations derive from financing rounds, meaning the paper value of Dacombe’s shares may fluctuate with future transactions. CoMind has similarly withheld its valuation. Consequently, pinning down an exact net worth figure remains inherently imprecise. Nevertheless, the latest financing generated sufficient private-market value for Forbes to rank him among the world’s youngest self-made billionaires and specifically identify him as Europe’s youngest. Forbes further notes that Dacombe belongs to an exclusive cohort of 11 self-made billionaires globally under the age of 30, only four of whom reside outside the United States.

The more compelling narrative spans ages 17 to 25. While the headline figure is $1 billion, the more telling metric is the eight-year timeframe. At 17, Dacombe was launching a brain-monitoring startup instead of pursuing higher education. By 25, he had founded a second company operating within one of the most capital-intensive and fiercely competitive segments of the AI sector. Neither venture resembles a typical consumer internet startup. CoMind is navigating the rigorous clinical and regulatory pathways required for medical technology, while Olix is engineering specialized computing hardware in a semiconductor landscape dominated by industry titans. This context reframes Dacombe’s ascent not as a tale of dropping out and instantly accumulating wealth, but as a progression of increasingly ambitious technical ventures. CoMind laid the foundation. Olix triggered the valuation surge. Investors provided the capital. And with an estimated 30% ownership stake, Dacombe’s personal financial standing scaled directly alongside Olix’s $3.3 billion valuation.

The next phase of Dacombe’s journey will hinge less on billionaire rankings and more on operational execution. Olix must still finalize its chip design and advance toward its 2027 product targets. Concurrently, CoMind is progressing through the clinical trials, regulatory approvals, and manufacturing scaling necessary to commercialize its technology. For now, however, the trajectory remains remarkably compressed: coding at 13, founding a company at 17, launching an AI chip venture in his early twenties, and achieving the title of Europe’s youngest self-made billionaire at 25. All accomplished before Olix delivers its first commercially targeted chips.